Format

Send to

Choose Destination
J Rheumatol. 2013 Aug;40(8):1428-33. doi: 10.3899/jrheum.130456.

Psoriasis outcome measures: a report from the GRAPPA 2012 annual meeting.

Author information

1
Department of Dermatology, Tufts Medical Center, Boston, Massachusetts 02111-1533, USA. agottlieb@tuftsmedicalcenter.org

Abstract

Psoriasis is a multisystem disease. The cutaneous and musculoskeletal manifestations (psoriatic arthritis) are well recognized. However, the other manifestations of psoriatic disease including metabolic syndrome, atherosclerotic cardiovascular disease, depression, poor self-esteem, and self-destructive habits including obesity, smoking and excess alcohol consumption are underappreciated. At the 2012 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), members addressed the need to develop uniform, validated, standardized outcome measures for psoriatic disease, measures that are useful to all stakeholders including patients, physicians, regulators, and payers.

KEYWORDS:

COMORBIDITIES; NATIONAL PSORIASIS FOUNDATION; OMERACT; PSORIASIS; PSORIATIC DISEASE

PMID:
23908539
DOI:
10.3899/jrheum.130456
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center